Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Impact of KIR/HLA ligand combinations on immune responses in malignant melanoma
Elissaveta Naumova, A. Mihaylova, Milena Ivanova, et al.
Cancer Immunology Immunotherapy (2006) Vol. 56, Iss. 1, pp. 95-100
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

The Yin and Yang of HLA and KIR in human disease
Smita Kulkarni, Maureen P. Martin, Mary Carrington
Seminars in Immunology (2008) Vol. 20, Iss. 6, pp. 343-352
Open Access | Times Cited: 356
Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response
Dongrui Wang, Xianlin Wu, Yingli Sun
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 290
Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands
Beatriz Sánchez-Correa, Sara Morgado, Inmaculada Gayoso, et al.
Cancer Immunology Immunotherapy (2011) Vol. 60, Iss. 8, pp. 1195-1205
Open Access | Times Cited: 127
Molecular Aspects and Future Perspectives of Cytokine-Based Anti-cancer Immunotherapy
Daria S. Chulpanova, Kristina V. Kitaeva, Andrew R. Green, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 92
Investigation of NK cell function and their modulation in different malignancies
Gordana Konjević, Vladimir Jurišić, Viktor Jović, et al.
Immunologic Research (2012) Vol. 52, Iss. 1-2, pp. 139-156
Open Access | Times Cited: 69
Polymorphisms of KIRs Gene and HLA-C Alleles in Patients with Ankylosing Spondylitis: Possible Association with Susceptibility to the Disease
Yulian Jiao, Chunyan Ma, Laicheng Wang, et al.
Journal of Clinical Immunology (2008) Vol. 28, Iss. 4, pp. 343-349
Closed Access | Times Cited: 72
HLA Associations with Nasopharyngeal Carcinoma
Xin Li, Ross M. Fasano, Ena Wang, et al.
Current Molecular Medicine (2009) Vol. 9, Iss. 6, pp. 751-765
Open Access | Times Cited: 60
Biomarkers of suppressed natural killer (NK) cell function in metastatic melanoma: Decreased NKG2D and increased CD158a receptors on CD3–CD16+ NK cells
Gordana Konjević, Katarina Mirjačić Martinović, Vladimir Jurišić, et al.
Biomarkers (2009) Vol. 14, Iss. 4, pp. 258-270
Closed Access | Times Cited: 58
Immunity at maternal–fetal interface: KIR/HLA (Allo)recognition*
Marina Alexandrova, Diana Manchorova, Tanya Dimova
Immunological Reviews (2022) Vol. 308, Iss. 1, pp. 55-76
Closed Access | Times Cited: 19
The Role of Killer Ig-like Receptors in Diseases from A to Z
Luisa Agnello, Anna Masucci, Martina Tamburello, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3242-3242
Open Access
The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?
Danillo G. Augusto
Frontiers in Genetics (2016) Vol. 7
Open Access | Times Cited: 33
Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B
Xuejun Gao, Yulian Jiao, Laicheng Wang, et al.
Clinical Immunology (2010) Vol. 137, Iss. 1, pp. 139-146
Closed Access | Times Cited: 40
In-vitro IL-2 or IFN-α-induced NKG2D and CD161 NK cell receptor expression indicates novel aspects of NK cell activation in metastatic melanoma patients
Gordana Konjević, Katarina Mirjačić Martinović, Ana Vuletić, et al.
Melanoma Research (2010) Vol. 20, Iss. 6, pp. 459-467
Closed Access | Times Cited: 37
Natural killer cell receptors: alterations and therapeutic targeting in malignancies
Gordana Konjević, Ana Vuletić, Katarina Mirjačić Martinović
Immunologic Research (2015) Vol. 64, Iss. 1, pp. 25-35
Closed Access | Times Cited: 33
Risk of Malignant Disease Among 1525 Adult Male US Veterans With Gaucher Disease
Ola Landgren, Ingemar Turesson, Gloria Gridley, et al.
Archives of Internal Medicine (2007) Vol. 167, Iss. 11, pp. 1189-1189
Closed Access | Times Cited: 42
FTY720 and SEW2871 reverse the inhibitory effect of S1P on natural killer cell mediated lysis of K562 tumor cells and dendritic cells but not on cytokine release
Johannes Rolin, Kristin Larsen Sand, Eirunn Knudsen, et al.
Cancer Immunology Immunotherapy (2009) Vol. 59, Iss. 4, pp. 575-586
Open Access | Times Cited: 34
Distribution of several activating and inhibitory receptors on CD3−CD56+ NK cells in regional lymph nodes of melanoma patients
Ana Vuletić, Vladimir Jurišić, Irena Jovanić, et al.
Journal of Surgical Research (2013) Vol. 183, Iss. 2, pp. 860-868
Closed Access | Times Cited: 28
Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15
Syh‐Jae Lin, Ming‐Ling Kuo, Hsiu-Shan Hsiao, et al.
PLoS ONE (2017) Vol. 12, Iss. 10, pp. e0186223-e0186223
Open Access | Times Cited: 26
Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells
Karin A. Vineretsky, Margaret R. Karagas, Brock C. Christensen, et al.
Cancer Research (2016) Vol. 76, Iss. 2, pp. 370-376
Open Access | Times Cited: 24
Distribution of Several Activating and Inhibitory Receptors on CD3−CD16+ NK Cells and Their Correlation with NK Cell Function in Healthy Individuals
Gordana Konjević, Katarina Mirjačić Martinović, Ana Vuletić, et al.
The Journal of Membrane Biology (2009) Vol. 230, Iss. 3, pp. 113-123
Closed Access | Times Cited: 30
Decitabine Inhibits Gamma Delta T Cell Cytotoxicity by Promoting KIR2DL2/3 Expression
Chao Niu, Min Li, Shan Zhu, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 21
Novel aspects of in vitro IL-2 or IFN-α enhanced NK cytotoxicity of healthy individuals based on NKG2D and CD161 NK cell receptor induction
Gordana Konjević, Katarina Mirjačić Martinović, Ana Vuletić, et al.
Biomedicine & Pharmacotherapy (2010) Vol. 64, Iss. 10, pp. 663-671
Closed Access | Times Cited: 25
The Stage Dependent Changes in NK Cell Activity and the Expression of Activating and Inhibitory NK Cell Receptors in Melanoma Patients
Katarina Mirjačić Martinović, Gordana Konjević, Nada Babović, et al.
Journal of Surgical Research (2010) Vol. 171, Iss. 2, pp. 637-649
Closed Access | Times Cited: 23
KIR gene variability in cutaneous malignant melanoma: influence of KIR2D/HLA-C pairings on disease susceptibility and prognosis
José A. Campillo, Isabel Legáz, María R. López-Álvarez, et al.
Immunogenetics (2013) Vol. 65, Iss. 5, pp. 333-343
Closed Access | Times Cited: 18
Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma
Sasijit Vejbaesya, Pradermchai Sae-Tam, Archrob Khuhapinant, et al.
Human Immunology (2014) Vol. 75, Iss. 7, pp. 673-676
Closed Access | Times Cited: 17
Page 1 - Next Page

Scroll to top